S1 ARRIVE Checklist - Controlling Immune Rejection Is a Fail-Safe System against Potential Tumorigenicity after Human iPSC-Derived Neural Stem Cell Transplantation
We aimed to generate human induced pluripotent stem cell (iPSC) lines from New Zealand donors. These lines are the first to be generated in New Zealand. Human dermal fibroblasts were collected from tw
BackgroundWe previously reported regenerative therapies for decompensated cirrhosis based on peripheral venous drip infusion using non-cultured whole bone marrow (BM) cells, or the less invasive cultu
Representative confocal line scan data and kymographs for an isogenic trio of c.MYH7C9123T R-GECO1.0 expressing hiPSC-CMs at day 30 and an isogenic pair of c.ACTC1G301A R-GECO1.0 expressing hiPSC-CMs
